Trademark: 79330277
Word
GP GETEIN BIOTECH, INC.
Status
Registered
Status Code
700
Status Date
Tuesday, August 22, 2023
Serial Number
79330277
Registration Number
7141193
Registration Date
Tuesday, August 22, 2023
Mark Type
3000
Filing Date
Wednesday, November 17, 2021
Published for Opposition
Tuesday, June 6, 2023

Trademark Owner History
Getein Biotech, Inc. - Original Registrant

Classifications
5 Medicines for human purposes, namely, medicines for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; biological preparations for medical purposes, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; diagnostic preparations for medical purposes; biochemical preparations for medical use, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Medicated serums for treatment of viral infections, diseases of the blood system, diseases of the immune system, skin diseases, diseases caused by bacterial exotoxins, bacterial infections, fungal infections, parasitic infections; chemical preparations for medical purposes, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Drugs for medical purposes for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; vaccines; dietetic substances adapted for medical use
10 Diagnostic testing apparatus for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers; Medical apparatus and instruments, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases diagnosis; urological apparatus and instruments for surgery, diagnostic testing, treatment, adjuvant therapy; X-ray apparatus for medical purposes
The mark consists of the wording "GP GETEIN BIOTECH, INC.", "GP" formed by horizontal lines and appearing to the left of "GETEIN BIOTECH, INC.".
The wording "GETEIN" has no meaning in a foreign language.
"BIOTECH, INC."

Trademark Events
Dec 11, 2023
Final Decision Transaction Processed By Ib
Nov 22, 2023
Final Disposition Notice Sent To Ib
Nov 22, 2023
Final Disposition Processed
Nov 22, 2023
Final Disposition Notice Created, To Be Sent To Ib
Aug 22, 2023
Notice Of Registration Confirmation Emailed
Aug 22, 2023
Registered-Principal Register
Jun 25, 2023
Notification Of Possible Opposition - Processed By Ib
Jun 7, 2023
Notification Of Possible Opposition Sent To Ib
Jun 7, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 6, 2023
Notification Processed By Ib
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2023
Published For Opposition
May 17, 2023
Notification Of Possible Opposition Sent To Ib
May 17, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 17, 2023
Notification Of Notice Of Publication E-Mailed
May 4, 2023
Approved For Pub - Principal Register
May 4, 2023
Examiner's Amendment Entered
May 4, 2023
Notification Of Examiners Amendment E-Mailed
May 4, 2023
Examiners Amendment E-Mailed
May 4, 2023
Examiners Amendment -Written
Apr 27, 2023
Teas/Email Correspondence Entered
Apr 27, 2023
Correspondence Received In Law Office
Apr 27, 2023
Teas Response To Office Action Received
Nov 21, 2022
Refusal Processed By Ib
Nov 3, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Nov 3, 2022
Refusal Processed By Mpu
Sep 10, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Sep 9, 2022
Non-Final Action Written
Aug 29, 2022
Assigned To Examiner
Jan 11, 2022
Application Filing Receipt Mailed
Jan 7, 2022
New Application Office Supplied Data Entered
Jan 6, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24